Rao, Q, Williamson, SR, Lopez-Beltran, A, Montironi, R, Huang, W, Eble, JN, Grignon, DJ, Koch, MO, Idrees, MT, Emerson, RE, Zhou, XJ, Zhang, S, Baldridge, LA, Cheng, L. Distinguishing Primary Adenocarcinoma of the Urinary Bladder from Secondary Involvement by Colorectal Adenocarcinoma: Extended Immunohistochemical Profiles Emphasizing Novel Markers. Mod Pathol. 2013 May; 26(5): 725–32. doi: 10.1038/modpathol.2012.229.CrossRefGoogle ScholarPubMed

Liu, H, Shi, J, Wilkerson, ML, Lin, F. Immunohistochemical Evaluation of GATA3 Expression in Tumors and Normal Tissues: A Useful Immunomarker for Breast and Urothelial Carcinomas. Am J Clin Pathol. 2012; 138: 57–64.Google Scholar

Miettinen, M, McCue, PA, Sarlomo-Rikala, M, et al. GATA3: A Multispecific but Potentially Useful Marker in Surgical Pathology: A Systematic Analysis of 2500 Epithelial and Nonepithelial Tumors. Am J Surg Pathol. 2013.Google Scholar

Chang, A, Amin, A, Gabrielson, E, et al. Utility of GATA3 Immunohistochemistry in Differentiating Urothelial Carcinoma from Prostate Adenocarcinoma and Squamous Cell Carcinomas of the Uterine Cervix, Anus, and Lung. Am J Surg Pathol. 2012; 36: 1472–76.Google Scholar

Genega, EM, Hutchinson, B, Reuter, VE, Gaudin, PB. Immunophenotype of High-grade Prostatic Adenocarcinoma and Urothelial Carcinoma. Mod Pathol. 2000; 13: 1186–91.Google Scholar

Mhawech, P, Uchida, T, Pelte, MF. Immunohistochemical Profile of High-grade Urothelial Bladder Carcinoma and Prostate Adenocarcinoma. Hum Pathol. 2002; 33: 1136–40.Google Scholar

Epstein, JI, Kuhajda, FP, Lieberman, PH. Prostate-specific Acid Phosphatase Immunoreactivity in Adenocarcinomas of the Urinary Bladder. Hum Pathol. 1986; 17: 939–42.Google Scholar

Wang, W, Epstein, JI. Small Cell Carcinoma of the Prostate. A Morphologic and Immunohistochemical Study of 95 Cases. Am J Surg Pathol. 2008; 32: 65–71.CrossRefGoogle ScholarPubMed

Yao, JL, Madeb, R, Bourne, P, et al. Small Cell Carcinoma of the Prostate: An Immunohistochemical Study. Am J Surg Pathol. 2006; 30: 705–12.Google Scholar

Agoff, SN, Lamps, LW, Philip, AT, et al. Thyroid Transcription Factor-1 Is Expressed in Extrapulmonary Small Cell Carcinomas but Not in Other Extrapulmonary Neuroendocrine Tumors. Mod Pathol. 2000; 13: 238–42.Google Scholar

Ordonez, NG. Value of Thyroid Transcription Factor-1 Immunostaining in Distinguishing Small Cell Lung Carcinomas from Other Small Cell Carcinomas. Am J Surg Pathol. 2000; 24: 1217–23.Google Scholar

Lotan, TL, Gupta, NS, Wang, W, et al. ERG Gene Rearrangements Are Common in Prostatic Small Cell Carcinomas. Mod Pathol. 2011; 24: 820–28.Google Scholar

Han, B, Mehra, R, Lonigro, RJ, et al. Fluorescence in Situ Hybridization Study Shows Association of PTEN Deletion with ERG Rearrangement During Prostate Cancer Progression. Mod Pathol. 2009; 22: 1083–93.Google Scholar

Williamson, SR, Zhang, S, Yao, JL, et al. ERG-TMPRSS2 Rearrangement Is Shared by Concurrent Prostatic Adenocarcinoma and Prostatic Small Cell Carcinoma and Absent in Small Cell Carcinoma of the Urinary Bladder: Evidence Supporting Monoclonal Origin. Mod Pathol. 2011; 24: 1120–27.CrossRefGoogle ScholarPubMed

Scheble, VJ, Braun, M, Wilbertz, T, et al. ERG Rearrangement in Small Cell Prostatic and Lung Cancer. Histopathology. 2010; 56: 937–43.CrossRefGoogle ScholarPubMed

Schelling, LA, Williamson, SR, Zhang, S, et al. Frequent TMPRSS2-ERG Rearrangement in Prostatic Small Cell Carcinoma Detected by Fluorescence in Situ Hybridization: The Superiority of Fluorescence in Situ Hybridization over ERG Immunohistochemistry. Hum Pathol. 2013.Google Scholar

Slater, D. Carcinoid Tumour of the Prostate Associated with Inappropriate ACTH Secretion. Br J Urol. 1985; 57: 591–92.CrossRefGoogle ScholarPubMed

Bodey, B, Bodey, B Jr, Kaiser, HE. Immunocytochemical Detection of Prostate Specific Antigen Expression in Human Primary and Metastatic Melanomas. Anticancer Res. 1997; 17: 2343–46.Google Scholar

Varinot, J, Drouin, S, Rouprêt, M, Montironi, R, Lopez-Beltran, A, Compérat, E. Prostate Cancer with Clear Cell Features and an Unusual Nested-like Pattern of Growth: A Case Report. Anal Quant Cytol Histol. 2012 Oct; 34(5): 289–92.Google Scholar

Cheng, L, MacLennan, GT, Lopez-Beltran, A, Montironi, R. Anatomic, Morphologic and Genetic Heterogeneity of Prostate Cancer: Implications for Clinical Practice. Expert Rev Anticancer Ther. 2012 Nov; 12(11): 1371–74. doi: 10.1586/era.12.127. No.Google Scholar

Morichetti, D, Mazzucchelli, R, Lopez-Beltran, A, Cheng, L, Scarpelli, M, Kirkali, Z, Montorsi, F, Montironi, R. Secondary Neoplasms of the Urinary System and Male Genital Organs. BJU Int. 2009 Sep; 104(6): 770–76.Google Scholar

Quick, Charles M. MDa, Gokden, Neriman MDa, Sangoi, Ankur R. MDb, Brooks, James D. MDc, McKenney, Jesse K. MDa. The Distribution of PAX-2 Immunoreactivity in the Prostate Gland, Seminal Vesicle, and Ejaculatory Duct: Comparison with Prostatic Adenocarcinoma and Discussion of Prostatic Zonal Embryogenesis. Human Pathology. 2010; 41: 1145–49.CrossRefGoogle ScholarPubMed

Harvey, Aaron M. MD, Grice, Beverly HTL, Hamilton, Candice HTL, Truong, Luan D. MD, Ro, Jae Y. MD, Ayala, Alberto G. MD, Zhai, Qihui ‘‘Jim’’ MD Diagnostic Utility of P504S/p63 Cocktail Prostate-specific Antigen, and Prostatic Acid Phosphatase in Scarpelli, M, Mazzucchelli, R, Barbisan, F, Santinelli, A, Lopez-Beltran, A, Cheng, L, Montironi, R. Is There a Role for Prostate Tumour Overexpressed-1 in the Diagnosis of HGPIN and of Prostatic Adenocarcinoma? A Comparison with Alpha-Methylacyl CoA Racemase. Int J Immunopathol Pharmacol. 2012 Jan–Mar; 25(1): 67–74.Google Scholar

Williamson, SR, Zhang, S, Yao, JL, Huang, J, Lopez-Beltran, A, Shen, S, Osunkoya, AO, MacLennan, GT, Montironi, R, Cheng, L. ERG-TMPRSS2 Rearrangement Is Shared by Concurrent Prostatic Adenocarcinoma and Prostatic Small Cell Carcinoma and Absent in Small Cell Carcinoma of the Urinary Bladder: Evidence Supporting Monoclonal Origin. Mod Pathol. 2011 Aug; 24(8): 1120–27. doi: 10.1038/modpathol.2011.56.CrossRefGoogle ScholarPubMed

Lopez-Beltran, A, Eble, John N, Bostwick, David G. Pleomorphic Giant Cell Carcinoma of the Prostate. Archives of Pathology and Laboratory Medicine. 2005; 129: 683–85.Google Scholar

Montironi, R, Scattoni, V, Mazzucchelli, R, Lopez-Beltran, A, Bostwick, DG, Montorsi, F. Atypical Foci Suspicious but Not Diagnostic of Malignancy in Prostate Needle Biopsies (Also Referred to as “Atypical Small Acinar Proliferation Suspicious for but Not Diagnostic of Malignancy”). Eur Urol. 2006 Oct; 50(4): 666–74.Google Scholar